Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers
Authors:
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 131, 119-129
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (#210572-152799-2001)
- University of Ottawa Medical Research Fund
This publication has 151 references indexed in Scilit:
- Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor2012
- Functional brain imaging of nicotinic effects on higher cognitive processesBiochemical Pharmacology, 2011
- A Roadmap for the Development and Validation of Event-Related Potential Biomarkers in Schizophrenia ResearchBiological Psychiatry, 2011
- Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in SchizophreniaBiological Psychiatry, 2010
- Meta-analysis of the acute effects of nicotine and smoking on human performancePsychopharmacology, 2010
- Choline transporter gene variation is associated with attention-deficit hyperactivity disorderJournal of Neurodevelopmental Disorders, 2009
- Effects of acute ultra‐low dose mecamylamine on cognition in adult attention‐deficit/hyperactivity disorder (ADHD)Human Psychopharmacology: Clinical and Experimental, 2009
- It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and moodProgress in Neurobiology, 2008
- Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to menBiochemical Pharmacology, 2007
- An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modificationPharmacology Biochemistry and Behavior, 2006